Fig. 2From: Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysisBase case scatter plot and cost-effectiveness acceptability curve (CEAC)Back to article page